XML 116 R102.htm IDEA: XBRL DOCUMENT v3.24.0.1
BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Purchase Price Allocated to the Underlying Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Thousands
Sep. 12, 2023
May 02, 2022
Dec. 31, 2021
Jun. 23, 2021
Apr. 14, 2021
Jan. 05, 2021
Dec. 31, 2023
Dec. 31, 2022
Acquisition                
Goodwill     $ 2,335,172       $ 2,367,120 $ 2,346,040
Customer relationships                
Acquisition                
Weighted Average Remaining Life (Years)             7 years 8 years
Trade name                
Acquisition                
Weighted Average Remaining Life (Years)             11 years 7 months 6 days 12 years 6 months
Developed Technology Rights [Member]                
Acquisition                
Weighted Average Remaining Life (Years)             7 years 3 months 18 days 7 years 9 months 18 days
OmicEra                
Acquisition                
Net operating assets   $ 2,586            
Developed technology   10,000            
Total identifiable assets acquired   12,586            
Net identifiable assets acquired   8,599            
Goodwill   10,809            
Net assets acquired   19,408            
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities   (3,987)            
Total purchase price   $ 19,408            
PreventionGenetics                
Acquisition                
Total purchase price     $ 185,381          
Ashion Analytics                
Acquisition                
Total purchase price         $ 109,999      
Thrive                
Acquisition                
Total purchase price           $ 2,187,054    
PFS Genomics                
Acquisition                
Total purchase price       $ 33,600        
Resolution Bioscience                
Acquisition                
Net operating assets $ 14,663              
Developed technology 26,000              
Total identifiable assets acquired 40,663              
Net identifiable assets acquired 33,511              
Goodwill 20,691              
Net assets acquired 54,202              
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities (7,152)              
Total purchase price 54,202              
Resolution Bioscience | Developed Technology Rights [Member]                
Acquisition                
Developed technology $ 26,000              
Weighted Average Remaining Life (Years) 17 years